The fact that everything looks different doesn't mean that all has changed...
Biblio
Export 23 results:
Author Title Type [ Year
] Filters: First Letter Of Last Name is R [Clear All Filters]
. Biomass-derived Lignin Nanoparticles for the Sustained Delivery of Vascular Endothelial Growth Factor-C. Molecular Pharmaceutics [Internet]. Submitted;. https://doi.org/10.1101/2025.04.23.649697
Preprint (8.34 MB)
Preprint (8.34 MB). Fetal-like reversion in the regenerating intestine is regulated by mesenchymal asporin. Cell Stem Cell [Internet]. 2025;32(4):613 - 626.e8. https://www.sciencedirect.com/science/article/pii/S1934590925000487
. Fetal-like reversion in the regenerating intestine is regulated by mesenchymal asporin. Cell Stem Cell [Internet]. 2025;32(4):613 - 626.e8. https://www.sciencedirect.com/science/article/pii/S1934590925000487
. Targeting Bacterial and Human Levodopa Decarboxylases for Improved Drug Treatment of Parkinson's Disease: Discovery and Characterization of New Inhibitors. European Journal of Pharmaceutical Sciences [Internet]. 2025;:107133. https://authors.elsevier.com/sd/article/S0928-0987(25)00132-0 Reunanen et al. 2025 - Targeting Bacterial and Human Levodopa Decarboxylases for Improved Drug Treatment of Parkinson’s Disease (1.18 MB)
Reunanen et al. 2025 - Targeting Bacterial and Human Levodopa Decarboxylases for Improved Drug Treatment of Parkinson’s Disease (1.18 MB). Gliflozins, sucrose and flavonoids are allosteric activators of lecithin-cholesterol acyltransferase. Scientific Reports [Internet]. 2024;14(1):26085. https://www.nature.com/articles/s41598-024-77104-3
. Expansion and collapse of VEGF diversity in major clades of the animal kingdom. Angiogenesis [Internet]. 2023;26(3):437 - 461. https://link.springer.com/10.1007/s10456-023-09874-9 Rauniyar et al. - 2023 - Expansion and collapse of VEGF diversity in major clades of the animal kingdom (3.59 MB)
Rauniyar et al. - 2023 - Expansion and collapse of VEGF diversity in major clades of the animal kingdom (3.59 MB). VEGF-C: The evolutionary origin, activation, and potential as a drug target [Internet]. [Helsinki. Finland]: University of Helsinki; 2023. http://hdl.handle.net/10138/357923 Rauniyar - 2023 - VEGF-C: The evolutionary origin, activation, and potential as a drug target (3.09 MB)
Rauniyar - 2023 - VEGF-C: The evolutionary origin, activation, and potential as a drug target (3.09 MB). Bioactive VEGF-C from E. coli. Scientific Reports [Internet]. 2022;12(1). https://www.nature.com/articles/s41598-022-22960-0 Rauniyar et al. - 2022 - Bioactive VEGF-C from E. coli (4.19 MB)
Rauniyar et al. - 2022 - Bioactive VEGF-C from E. coli (4.19 MB). KLK3/PSA and cathepsin D activate VEGF-C and VEGF-D. eLife [Internet]. 2019;8:e44478. https://elifesciences.org/articles/44478 Jha & Rauniyar et al. 2019 (3.84 MB)
Jha & Rauniyar et al. 2019 (3.84 MB). Biology of Vascular Endothelial Growth Factor C in the Morphogenesis of Lymphatic Vessels. Frontiers in Biotechnology and Bioengineering [Internet]. 2018;6. https://www.frontiersin.org/articles/10.3389/fbioe.2018.00007/full Rauniyar et al. - Biology of Vascular Endothelial Growth Factor C in the Morphogenesis of Lymphatic Vessels (4.42 MB)
Rauniyar et al. - Biology of Vascular Endothelial Growth Factor C in the Morphogenesis of Lymphatic Vessels (4.42 MB). Key molecules in lymphatic development, function, and identification. Annals of Anatomy - Anatomischer Anzeiger [Internet]. 2018;219:25 - 34. http://linkinghub.elsevier.com/retrieve/pii/S0940960218300712 1-s2.0-S0940960218300712-main.pdf (2.19 MB)
1-s2.0-S0940960218300712-main.pdf (2.19 MB). Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1. Scientific Reports [Internet]. 2017;7(1):4916. https://www.nature.com/articles/s41598-017-04982-1
. Lymphatic Vessels in Regenerative Medicine and Tissue Engineering. Tissue Engineering Part B [Internet]. 2016;22(5):1-13. http://online.liebertpub.com/doi/10.1089/ten.TEB.2016.0034 Schaupper et al. Tissue Engineering Part B. Review (postprint manuscript = accepted version after peer review). (697.3 KB)
Schaupper et al. Tissue Engineering Part B. Review (postprint manuscript = accepted version after peer review). (697.3 KB). Lymphatic Vessels in Regenerative Medicine and Tissue Engineering. Tissue Engineering Part B [Internet]. 2016;22(5):1-13. http://online.liebertpub.com/doi/10.1089/ten.TEB.2016.0034 Schaupper et al. Tissue Engineering Part B. Review (postprint manuscript = accepted version after peer review). (697.3 KB)
Schaupper et al. Tissue Engineering Part B. Review (postprint manuscript = accepted version after peer review). (697.3 KB). Functional Dissection of the CCBE1 Protein: A Crucial Requirement for the Collagen Repeat Domain. Circ Res [Internet]. 2015;116(10):1660-1669. http://circres.ahajournals.org/content/116/10/1660.long
. Ischemia-Reperfusion Injury Enhances Lymphatic Endothelial VEGFR3 and Rejection in Cardiac Allografts. American Journal of Transplantation [Internet]. 2015;16(4):1160-1172. http://onlinelibrary.wiley.com/doi/10.1111/ajt.13564/abstract
. Critical role of VEGF-C/VEGFR-3 signaling in innate and adaptive immune responses in experimental obliterative bronchiolitis. Am J Pathol. 2012;181(5):1607-20.
. VEGF-C/VEGFR-3 Signaling Regulates Inflammatory Response in Development of Obliterative Airway Disease. Journal of Heart and Lung Transplantation. 2011;30:S118 - S118.
. Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels. Cancer Res [Internet]. 2005;65(11):4739 - 46. http://view.ncbi.nlm.nih.gov/pubmed/15930292 Yulong He et al., Cancer Research 2005 (1.82 MB)
Yulong He et al., Cancer Research 2005 (1.82 MB). Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol [Internet]. 2004;5(1):74 - 80. http://view.ncbi.nlm.nih.gov/pubmed/14634646 Marika Kärkkäinen et al., Nature Immunology 2004 (3.01 MB) Marika Kärkkäinen et al., Nature Immunology 2004, supplementary data 1 (1.27 MB) Marika Kärkkäinen et al., Nature Immunology 2004, supplementary data 2 (1.23 MB)
Marika Kärkkäinen et al., Nature Immunology 2004 (3.01 MB) Marika Kärkkäinen et al., Nature Immunology 2004, supplementary data 1 (1.27 MB) Marika Kärkkäinen et al., Nature Immunology 2004, supplementary data 2 (1.23 MB). VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol [Internet]. 2003;161(6):1163 - 77. http://view.ncbi.nlm.nih.gov/pubmed/12810700 Holger Gerhardt et al., The Journal of Biological Chemistry 2003 (2.24 MB)
Holger Gerhardt et al., The Journal of Biological Chemistry 2003 (2.24 MB). Intravascular adenovirus-mediated VEGF-C gene transfer reduces neointima formation in balloon-denuded rabbit aorta. Circulation [Internet]. 2000;102(18):2262 - 8. http://view.ncbi.nlm.nih.gov/pubmed/11056103 Mikko Hiltunen et al., Circulation 2000 (1.44 MB)
Mikko Hiltunen et al., Circulation 2000 (1.44 MB). Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science (80- ) [Internet]. 1997;276(5317):1423 - 5. http://view.ncbi.nlm.nih.gov/pubmed/9162011 Michael Jeltsch et al., Science 1997 (293.65 KB)
Michael Jeltsch et al., Science 1997 (293.65 KB)